Acquisition highlights of Avammune Therapeutics and a snapshot of its key metrics.

Founded in 2020, Avammune Therapeutics operates in Health Tech industry. Initially focused on developing cutting-edge therapies for immune-related disorders, the company has evolved to offer personalized treatment options for a wide range of conditions. In recent months, Avammune Therapeutics has launched a new product line aimed at enhancing patient outcomes, solidifying its position as a key player in the healthcare sector.

Arun B Papaiah

Srinivasan Namala

Aditya Kulkarni

Funding highlights of Avammune Therapeutics and a snapshot of its key metrics.

The Chennai Angels

1Crowd

IvyCap Ventures

Kotak Alternate Asset Managers

Shastra VC

Capital 2B

Investment highlights of Avammune Therapeutics and a snapshot of its key metrics.

Avammune Therapeutics - A Health Tech Funded Company Based Out Of Philadelphia

Avammune Therapeutics

A snapshot of highlights, scale, and metrics

An overview of key people in Avammune Therapeutics.

A Health Tech Funded Company Based Out Of Philadelphia

Avammune Therapeutics - Latest News, Analysis, Funding, Financials & More